Cargando…
Gene therapy by electroporation for the treatment of chronic renal failure in companion animals
BACKGROUND: Growth hormone-releasing hormone (GHRH) plasmid-based therapy for the treatment of chronic renal failure and its complications was examined. Companion dogs (13.1 ± 0.8 years, 29.4 ± 5.01 kg) and cats (13.2 ± 0.9 years, 8.5 ± 0.37 kg) received a single 0.4 mg or 0.1 mg species-specific pl...
Autores principales: | Brown, Patricia A, Bodles-Brakhop, Angela M, Pope, Melissa A, Draghia-Akli, Ruxandra |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663557/ https://www.ncbi.nlm.nih.gov/pubmed/19149896 http://dx.doi.org/10.1186/1472-6750-9-4 |
Ejemplares similares
-
Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006) -
Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
por: Laddy, Dominick J., et al.
Publicado: (2008) -
Opportunities for vaccine research in Europe
por: Gancberg, David, et al.
Publicado: (2015) -
The selection of experts evaluating health projects for the EU Sixth Framework Program
por: Quaglio, GianLuca, et al.
Publicado: (2011) -
P14-08. Intramuscular DNA delivery by electroporation leads to greatly enhanced systemic and mucosal immune responses and control of SIVmac251 challenge
por: Pavlakis, GN, et al.
Publicado: (2009)